Dr Dana DiRenzo is a third year fellow in the Division of Rheumatology at Johns Hopkins University in Baltimore, Maryland, USA. She will be joining the faculty as clinical instructor upon completion of her fellowship. She received her medical degree from Temple University School of Medicine, Philadelphia, Pennsylvania, and residency training from the University of Maryland. She also received a Masters of Health Science from the Johns Hopkins Bloomberg School of Public Health in Baltimore. Her clinical interests include inflammatory arthritis with research interests in mental health including non-pharmacologic management strategies as well as complementary and alternative therapies.
Browse topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA
Anifrolumab for the treatment of SLE
JAK inhibitor safety: Weighing up the data and understanding the risks
Rituximab and rheumatology practice in the COVID-19 era
Safety snapshot: Upadacitinib in patients with PsA
Repurposing rheumatology drugs for COVID-19
Telemedicine in rheumatology: COVID-19 and beyond
Managing PsA in resource-limited settings
Conferences